Thuy V Tran
Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )
Most Active Art Unit | 2821 |
Art Unit(s) | 2821, 2844, 2856, 2814 |
Total Applications | 2202 |
Issued Applications | 1909 |
Pending Applications | 47 |
Abandoned Applications | 246 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16282569
[patent_doc_number] => 20200276171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/877959
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877959 | Combination therapy using azabicyclo compound for cancer | May 18, 2020 | Issued |
Array
(
[id] => 17434709
[patent_doc_number] => 11260015
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Compositions and methods for improving skin appearance
[patent_app_type] => utility
[patent_app_number] => 16/877315
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 9802
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877315 | Compositions and methods for improving skin appearance | May 17, 2020 | Issued |
Array
(
[id] => 16389559
[patent_doc_number] => 20200330500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Mecobalamin for Relieving Emergency Drug Poisoning
[patent_app_type] => utility
[patent_app_number] => 15/930954
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930954
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930954 | Mecobalamin for Relieving Emergency Drug Poisoning | May 12, 2020 | Abandoned |
Array
(
[id] => 18369014
[patent_doc_number] => 11649168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Purification method of high-purity n-tetrasilane
[patent_app_type] => utility
[patent_app_number] => 16/870539
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1448
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870539 | Purification method of high-purity n-tetrasilane | May 7, 2020 | Issued |
Array
(
[id] => 16824360
[patent_doc_number] => 20210139653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PROCESS FOR THE PRODUCTION OF BIOPRODUCTS FROM LIGNOCELLULOSIC MATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/866266
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 450
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866266
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866266 | Process for the production of bioproducts from lignocellulosic material | May 3, 2020 | Issued |
Array
(
[id] => 16253442
[patent_doc_number] => 20200262816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 16/865799
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 866
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865799 | Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | May 3, 2020 | Issued |
Array
(
[id] => 16326888
[patent_doc_number] => 20200297853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/861494
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861494 | Carbohydrate conjugates as delivery agents for oligonucleotides | Apr 28, 2020 | Issued |
Array
(
[id] => 16236871
[patent_doc_number] => 20200254105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => DRUG COMPOSITION FOR PARENTERAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 16/858810
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858810 | Drug composition for parenteral administration | Apr 26, 2020 | Issued |
Array
(
[id] => 16229343
[patent_doc_number] => 10736872
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-08-11
[patent_title] => Pharmaceutical mixture to treat statin induced vascular calcification
[patent_app_type] => utility
[patent_app_number] => 16/853519
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5818
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853519 | Pharmaceutical mixture to treat statin induced vascular calcification | Apr 19, 2020 | Issued |
Array
(
[id] => 17149446
[patent_doc_number] => 11142508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Bisphenol derivatives and their use as androgen receptor activity modulators
[patent_app_type] => utility
[patent_app_number] => 16/848061
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28282
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848061 | Bisphenol derivatives and their use as androgen receptor activity modulators | Apr 13, 2020 | Issued |
Array
(
[id] => 16523660
[patent_doc_number] => 20200397740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/841807
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841807 | 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER | Apr 6, 2020 | Abandoned |
Array
(
[id] => 16389531
[patent_doc_number] => 20200330472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/841097
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841097 | METHOD OF TREATING CANCER | Apr 5, 2020 | Abandoned |
Array
(
[id] => 16204803
[patent_doc_number] => 20200237793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/840026
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840026 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 2, 2020 | Abandoned |
Array
(
[id] => 16189312
[patent_doc_number] => 20200230161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/840059
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840059 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 2, 2020 | Abandoned |
Array
(
[id] => 16769674
[patent_doc_number] => 10980756
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-04-20
[patent_title] => Methods of treatment
[patent_app_type] => utility
[patent_app_number] => 16/835307
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38956
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835307 | Methods of treatment | Mar 30, 2020 | Issued |
Array
(
[id] => 16341731
[patent_doc_number] => 20200306381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE
[patent_app_type] => utility
[patent_app_number] => 16/832620
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832620 | Compositions and methods for altering macrophage phenotype | Mar 26, 2020 | Issued |
Array
(
[id] => 17156092
[patent_doc_number] => 20210317143
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-10-14
[patent_title] => BORONIC ESTER PRODRUGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/825269
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825269 | BORONIC ESTER PRODRUGS AND USES THEREOF | Mar 19, 2020 | Pending |
Array
(
[id] => 17156092
[patent_doc_number] => 20210317143
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-10-14
[patent_title] => BORONIC ESTER PRODRUGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/825269
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825269 | BORONIC ESTER PRODRUGS AND USES THEREOF | Mar 19, 2020 | Pending |
Array
(
[id] => 16153695
[patent_doc_number] => 20200215080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => 17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/820407
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820407 | 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors | Mar 15, 2020 | Issued |
Array
(
[id] => 16924327
[patent_doc_number] => 11045786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Superabsorbent materials and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 16/807004
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 6
[patent_no_of_words] => 10214
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807004 | Superabsorbent materials and methods of making the same | Mar 1, 2020 | Issued |